SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing a surge in investor attention as the community anticipates news regarding potential Joint Development Agreements and commercial licensing deals tied to its Mears Silicon Technology, particularly within the Gate-All-Around and DRAM sectors. Traders are closely monitoring the stock's significant volume and price volatility, driven by speculation over partnerships with major semiconductor foundries and equipment manufacturers amid a broader focus on AI infrastructure.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing a massive surge in market interest, driven by speculation over potential partnerships with major hyperscalers and its critical role in AI optical interconnects. The community is actively discussing the stock's parabolic volume and momentum, with longs celebrating the potential for a sustained breakout while shorts remain under intense pressure.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is experiencing significant volatility and downward pressure as shareholders react to a recent shelf offering and concerns over clinical trial timelines. While the community remains polarized, with some investors accumulating shares on dips anticipating future trial data and a potential short squeeze, others are expressing frustration over the persistent selling and lack of clear upward momentum.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is currently trending as retail investors react to a recent convertible notes offering, which triggered short-term volatility despite analysts viewing it as a move to strengthen the company's balance sheet for long-term R&D. The community remains deeply divided, with many long-term holders expressing frustration over price stagnation and leadership execution, while others highlight the company's $2 billion cash pile and upcoming clinical data catalysts as reasons to remain bullish.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is gaining momentum as investors eye upcoming industry events and potential integration news, with the community actively debating the project's utility versus broader market volatility. Enthusiasts are focusing on long-term growth and technical accumulation, while discussion remains divided between those expecting significant adoption and others expressing caution over price trends.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging alongside other semiconductor leaders as strong CPU performance data from Intel drives sector-wide momentum and investor FOMO. The community is actively debating whether this parabolic rally is a sustainable AI-driven breakout or an overextended bubble, with many traders focused on short squeezes and aggressive price action.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) has captured significant community attention due to its historic streak of consecutive green sessions and parabolic price action, prompting intense debate over whether it represents a sustainable AI-driven bull run or an overdue blow-off top. Investors are actively discussing the risks of extreme overbought conditions while weighing tactical hedging strategies, such as using inverse ETFs, against a bullish narrative centered on unrelenting demand for AI infrastructure.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride-share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company was founded by Peter Beck in 2006 and is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently gaining investor attention and upward momentum driven by consistent launch execution, a strong backlog of defense and space systems contracts, and anticipation surrounding the broader space sector's upcoming catalytic events. The community is actively discussing the company's competitive positioning as a vertically integrated prime contractor, with many investors focusing on successful mission deliveries while debating the impact of upcoming earnings and future growth prospects.

MaxLinear, Inc. engages in the provision of communications systems-on-chip (SoC) solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling, and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.

MaxLinear Inc

MaxLinear is currently trending as traders aggressively reprice the stock following a significant earnings beat and raised guidance that highlights its growing role in AI-driven data center infrastructure. The community remains divided, with bulls pointing to fundamental momentum and institutional interest, while bears warn of a potential overvaluation and pump-and-dump mechanics after the recent parabolic price move.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing intense volatility and record-breaking momentum, with community debate centered on whether this surge represents a sustainable AI-driven growth cycle or a speculative bubble reminiscent of the dot-com era. Traders are actively discussing the extreme technical overextension and concentration of the trade, with many weighing the risks of a blow-off top against the potential for continued upside from data center demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Westlake Chemical Partners Announce First Quarter 2026 Conference Call

Westlake Chemical Partners (NYSE: WLKP) will release its first quarter 2026 earnings prior to the market opening on Tuesday, May 5, 2026. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the...

Westlake Chemical Partners Appoints Jonathan H. Baksht as Senior Vice President and Chief Financial Officer

Westlake Chemical Partners LP (NYSE: WLKP) (the "Partnership") announced today that Mr. Jonathan H. Baksht will be joining the Partnership as Senior Vice President and Chief Financial Officer and as a director of Westlake Chemical Partners GP LLC, the general partner of the Partnership (the General...

Westlake Chemical Partners LP (NYSE:WLKP) Short Interest Down 20.9% in March

Westlake Chemical Partners LP (NYSE:WLKP - Get Free Report) was the target of a significant drop in short interest during the month of March. As of March 31st, there was short interest totaling...

Westlake Chemical Partners (NYSE:WLKP) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Westlake Chemical Partners from a "buy" rating to a "strong-buy" rating in a report on Saturday...

Wall Street Zen Downgrades Westlake Chemical Partners (NYSE:WLKP) to Buy

Wall Street Zen downgraded Westlake Chemical Partners from a "strong-buy" rating to a "buy" rating in a research note on Saturday...

Westlake Chemical Partners LP Filed Annual Report

Westlake Chemical Partners LP (NYSE: WLKP) (the 'Partnership') announced that it filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 with the Securities and Exchange...

Westlake Chemical Partners (NYSE:WLKP) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Westlake Chemical Partners (NYSE:WLKP - Get Free Report) announced its earnings results on Tuesday. The basic materials company reported $0.41 earnings per share for the quarter, missing the...

Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2025 Results

Westlake Chemical Partners LP (NYSE: WLKP) (the 'Partnership') today reported net income attributable to the Partnership in the fourth quarter of 2025 of $14.5 million, or $0.41 per limited partner...

WLKP Makes Notable Cross Below Critical Moving Average

In trading on Tuesday, shares of Westlake Chemical Partners LP (Symbol: WLKP) crossed below their 200 day moving average of $21.05, changing hands as low as $21.01 per share. Westlake Chemical...

Westlake Chemical Partners (WLKP) Expected to Announce Earnings on Tuesday

Westlake Chemical Partners (NYSE:WLKP) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...

Westlake Chemical Partners LP engages in the operation, acquisition and development of ethylene production facilities and related assets. It is also involved in the manufacture and marketing of basic chemicals, polymers, and fabricated building products. The company was founded on March 14, 2014 and is headquartered in Houston, TX.

Current Price	$22.56
Prev Close	$22.46
Open	$22.27
Dividend Yield	9.92%
50-Day Moving Average	$22.10
Beta	0.30
Avg. Volume	35,587.90
PE Ratio	16.25

52-Week High	$23.80
52-Week Low	$17.75
Market Capitalization	$791.62M
EPS (Annual)	$1.38
Price to Book	1.58
Revenue Per Employee	$7.53M

WLKP
Westlake Chemical Partners LP

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest WLKP News

WLKPWestlake Chemical Partners LP